![Long-term follow-up of high-risk neuroblastoma survivors treated with high-dose chemotherapy and stem cell transplantation rescue | Bone Marrow Transplantation Long-term follow-up of high-risk neuroblastoma survivors treated with high-dose chemotherapy and stem cell transplantation rescue | Bone Marrow Transplantation](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41409-021-01258-1/MediaObjects/41409_2021_1258_Fig1_HTML.png)
Long-term follow-up of high-risk neuroblastoma survivors treated with high-dose chemotherapy and stem cell transplantation rescue | Bone Marrow Transplantation
![Clinically-relevant treatment of PDX models reveals patterns of neuroblastoma chemoresistance | bioRxiv Clinically-relevant treatment of PDX models reveals patterns of neuroblastoma chemoresistance | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2022/04/02/2022.04.01.486670/F4.large.jpg)
Clinically-relevant treatment of PDX models reveals patterns of neuroblastoma chemoresistance | bioRxiv
![JOURNAL CLUB HIGH-DOSE RAPID AND STANDARD INDUCTION CHEMOTHERAPY FOR PATIENTS AGED OVER 1 YEAR WITH STAGE 4 NEUROBLASTOMA: A RANDOMISED TRIAL † Lancet. - ppt download JOURNAL CLUB HIGH-DOSE RAPID AND STANDARD INDUCTION CHEMOTHERAPY FOR PATIENTS AGED OVER 1 YEAR WITH STAGE 4 NEUROBLASTOMA: A RANDOMISED TRIAL † Lancet. - ppt download](https://images.slideplayer.com/14/4477551/slides/slide_8.jpg)
JOURNAL CLUB HIGH-DOSE RAPID AND STANDARD INDUCTION CHEMOTHERAPY FOR PATIENTS AGED OVER 1 YEAR WITH STAGE 4 NEUROBLASTOMA: A RANDOMISED TRIAL † Lancet. - ppt download
![Forest plot of comparison: 1 Rapid COJEC versus standard induction,... | Download Scientific Diagram Forest plot of comparison: 1 Rapid COJEC versus standard induction,... | Download Scientific Diagram](https://www.researchgate.net/publication/277086302/figure/fig1/AS:289342846193667@1445996118096/Forest-plot-of-comparison-1-Rapid-COJEC-versus-standard-induction-outcome-11-Complete.png)
Forest plot of comparison: 1 Rapid COJEC versus standard induction,... | Download Scientific Diagram
![Full article: Macrophage infiltration promotes regrowth in MYCN-amplified neuroblastoma after chemotherapy Full article: Macrophage infiltration promotes regrowth in MYCN-amplified neuroblastoma after chemotherapy](https://www.tandfonline.com/cms/asset/016edad4-7d89-4255-9d87-be899be2a145/koni_a_2184130_f0005_oc.jpg)
Full article: Macrophage infiltration promotes regrowth in MYCN-amplified neuroblastoma after chemotherapy
![PDF] Topotecan-Vincristine-Doxorubicin in Stage 4 High-Risk Neuroblastoma Patients Failing to Achieve a Complete Metastatic Response to Rapid COJEC: A SIOPEN Study | Semantic Scholar PDF] Topotecan-Vincristine-Doxorubicin in Stage 4 High-Risk Neuroblastoma Patients Failing to Achieve a Complete Metastatic Response to Rapid COJEC: A SIOPEN Study | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/61dfb3a5ee37540ef03aaa30a65508f621b16f2b/4-Table1-1.png)
PDF] Topotecan-Vincristine-Doxorubicin in Stage 4 High-Risk Neuroblastoma Patients Failing to Achieve a Complete Metastatic Response to Rapid COJEC: A SIOPEN Study | Semantic Scholar
![Randomized Trial of Prophylactic Granulocyte Colony-Stimulating Factor During Rapid COJEC Induction in Pediatric Patients With High-Risk Neuroblastoma: The European HR-NBL1/SIOPEN Study | Journal of Clinical Oncology Randomized Trial of Prophylactic Granulocyte Colony-Stimulating Factor During Rapid COJEC Induction in Pediatric Patients With High-Risk Neuroblastoma: The European HR-NBL1/SIOPEN Study | Journal of Clinical Oncology](https://ascopubs.org/cms/10.1200/JCO.2009.27.3524/asset/images/zlj9991001940003.jpeg)
Randomized Trial of Prophylactic Granulocyte Colony-Stimulating Factor During Rapid COJEC Induction in Pediatric Patients With High-Risk Neuroblastoma: The European HR-NBL1/SIOPEN Study | Journal of Clinical Oncology
Treatment and management of newly diagnosed patients with high-risk neuroblastoma (not patients currently registered on HR-NBL-1
![High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial - The Lancet Oncology High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/4c6a9f60-52dc-42f1-9896-1075dd5b6b19/gr2.jpg)
High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial - The Lancet Oncology
![Randomized Trial of Prophylactic Granulocyte Colony-Stimulating Factor During Rapid COJEC Induction in Pediatric Patients With High-Risk Neuroblastoma: The European HR-NBL1/SIOPEN Study | Journal of Clinical Oncology Randomized Trial of Prophylactic Granulocyte Colony-Stimulating Factor During Rapid COJEC Induction in Pediatric Patients With High-Risk Neuroblastoma: The European HR-NBL1/SIOPEN Study | Journal of Clinical Oncology](https://ascopubs.org/cms/10.1200/JCO.2009.27.3524/asset/images/zlj9991001940001.jpeg)
Randomized Trial of Prophylactic Granulocyte Colony-Stimulating Factor During Rapid COJEC Induction in Pediatric Patients With High-Risk Neuroblastoma: The European HR-NBL1/SIOPEN Study | Journal of Clinical Oncology
![High frequency of viridians group streptococci bacteremia in pediatric neuroblastoma high-risk patients during induction chemotherapy | Scientific Reports High frequency of viridians group streptococci bacteremia in pediatric neuroblastoma high-risk patients during induction chemotherapy | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-023-31805-3/MediaObjects/41598_2023_31805_Fig1_HTML.png)
High frequency of viridians group streptococci bacteremia in pediatric neuroblastoma high-risk patients during induction chemotherapy | Scientific Reports
![Clinical impact of primary tumour 123ImIBG response to induction chemotherapy in children with high-risk neuroblastoma | International Journal of Clinical Oncology Clinical impact of primary tumour 123ImIBG response to induction chemotherapy in children with high-risk neuroblastoma | International Journal of Clinical Oncology](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs10147-021-02039-y/MediaObjects/10147_2021_2039_Fig2_HTML.png)
Clinical impact of primary tumour 123ImIBG response to induction chemotherapy in children with high-risk neuroblastoma | International Journal of Clinical Oncology
![Extended induction chemotherapy does not improve the outcome for high-risk neuroblastoma patients: results of the randomized open-label GPOH trial NB2004-HR - Annals of Oncology Extended induction chemotherapy does not improve the outcome for high-risk neuroblastoma patients: results of the randomized open-label GPOH trial NB2004-HR - Annals of Oncology](https://www.annalsofoncology.org/cms/asset/937ec2c5-ef03-442b-ae9a-0722707484ec/gr1.jpg)
Extended induction chemotherapy does not improve the outcome for high-risk neuroblastoma patients: results of the randomized open-label GPOH trial NB2004-HR - Annals of Oncology
![Randomized Trial of Two Induction Therapy Regimens for High-Risk Neuroblastoma: HR-NBL1.5 International Society of Pediatric Oncology European Neuroblastoma Group Study | Semantic Scholar Randomized Trial of Two Induction Therapy Regimens for High-Risk Neuroblastoma: HR-NBL1.5 International Society of Pediatric Oncology European Neuroblastoma Group Study | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e545787e1079eab546e6b0c6503a40e01ed97107/3-Figure1-1.png)